famotidine has been researched along with Bladder Diseases in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, H | 1 |
| Zhou, Y | 1 |
| Ping, Y | 1 |
| Tian, S | 1 |
| Li, G | 1 |
| Cui, Y | 1 |
| Zheng, B | 1 |
1 other study available for famotidine and Bladder Diseases
| Article | Year |
|---|---|
The combination of loratadine with famotidine to relieve the symptoms of urinary frequency in female patients with bladder function disorders：First report of three cases.
Topics: Adult; Drug Therapy, Combination; Famotidine; Female; Histamine H1 Antagonists; Humans; Loratadine; | 2019 |